Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account
Etex Corp. — Predicate Candidate Screening
18 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
105 daysmedian FDA review time
403 days90th percentile
18clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K100883 | CARRIGEN | Etex Corp. | 2010-12-21 | 266 | 0 |
| K101557 | GAMMA-BSM, BETA-BSM, EQUIVABONE, CARIGEN | Etex Corp. | 2010-07-01 | 27 | 0 |
| K093447 | CARRIGEN | Etex Corp. | 2010-02-18 | 105 | 0 |
| K091729 | ALPHA-BSM, BETA-BSM, GAMMA-BSM, EQUIVABONE | Etex Corp. | 2009-12-23 | 195 | 0 |
| K091607 | ALPHA-BSM, BETA-BSM, GAMMA-BSM, EQUIVABONE | Etex Corp. | 2009-11-02 | 152 | 0 |
| K090855 | EQUIVABONE OSTEOINDUCTIVE BONE GRAFT SUBSTITUTE | Etex Corp. | 2009-09-18 | 172 | 0 |
| K090310 | EQUIVABONE | Etex Corp. | 2009-03-24 | 46 | 0 |
| K090242 | GAMMA-BSM, BETA-BSM | Etex Corp. | 2009-02-20 | 18 | 0 |
| K080329 | CAP PLUS, EQUIVABONE, CAP/DBM | Etex Corp. | 2008-04-28 | 81 | 0 |
| K063050 | CAP PLUS | Etex Corp. | 2007-11-19 | 411 | 0 |
| K072636 | A-BSM BONE SUBSTITUTE MATERIAL | Etex Corp. | 2007-10-23 | 35 | 0 |
| K072355 | OSSIFUSE BONE SUBSTITUTE MATERIAL | Etex Corp. | 2007-09-26 | 35 | 0 |
| K062630 | OSSIPRO BONE SUBSTITUTE MATERIAL | Etex Corp. | 2007-06-28 | 296 | 0 |
| K033138 | CAP3 BONE SUBSTITUTE MATERIAL | Etex Corp. | 2003-12-02 | 63 | 0 |
| K032307 | CAP BONE SUBSTITUTE MATERIAL | Etex Corp. | 2003-10-24 | 91 | 0 |
| K983009 | BSM- BONE SUBSTITUTE MATERIAL | Etex Corp. | 1998-11-25 | 89 | 0 |
| K962548 | BSM BONE SUBSTITUTE MATERIAL KIT | Etex Corp. | 1997-08-05 | 403 | 0 |
| K935696 | ETEX HA HIP REPLACEMENT SYSTEM | Etex Corp. | 1994-07-22 | 234 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda